Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Suspended 1Recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Ovarian Neoplasms 3Stomach Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Glioma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 19Specimen Handling 19Biopsy 13Magnetic Resonance Spectroscopy 12Carboplatin 11Paclitaxel 10Pemetrexed 8Nivolumab 7Irinotecan 7Gemcitabine 7trastuzumab deruxtecan 6Fulvestrant 6Radiosurgery 5Leucovorin 5Fluorouracil 5Cisplatin 5Cetuximab 5Bevacizumab 5palbociclib 4durvalumab 4Taxes 4Oxaliplatin 4Letrozole 4Docetaxel 4ribociclib 3olaparib 3Trastuzumab 3Panitumumab 3Midazolam 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Metastasis × ipatasertib × 30 days × Clear all
NCT05564377 2026-06-12

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
2,900 enrolled
Gynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

NCT05554380 2026-05-22

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

National Cancer Institute (NCI)

Phase 2 Suspended
33 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡